AI assistant
DAXOR CORP — Capital/Financing Update 2026
Jan 26, 2026
34445_rns_2026-01-26_e214ce9d-22f5-4ca0-a66d-9f7e48703f2d.zip
Capital/Financing Update
Open in viewerOpens in your device viewer
Field: Rule-Page
Field: /Rule-Page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 23, 2026
Daxor Corporation
Field: Rule-Page
Field: /Rule-Page
(Exact name of registrant as specified in its charter)
| New
York | 811-22684 | 13-2682108 |
| --- | --- | --- |
| (State
or other jurisdiction of
incorporation) | (Commission File
Number) | (IRS
Employer Identification
No.) |
| 107
Meco Lane , Oak Ridge , TN | 37830 |
| --- | --- |
| (Address
of principal executive offices) | (Zip
Code) |
212 - 330-8500
Field: Rule-Page
Field: /Rule-Page
Registrant’s telephone number, including area code
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):
| ☐ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| --- | --- |
| ☐ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b)
of the Act: |
| Title
of each class | Trading
Symbol(s) | Name
of each exchange on which registered |
| --- | --- | --- |
| Common
Stock $0.01 par value | DXR | Nasdaq |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Field: Rule-Page
Field: /Rule-Page
Field: Page; Sequence: 1
Field: /Page
Item 1.01 – Entry Into a Definitive Material Agreement
On January 23, 2026, Daxor Corporation (“we” or “us”) entered into a definitive securities purchase agreement with certain investors pursuant to which we issued and sold an aggregate of 765,958 registered shares of our common stock at $11.75 per share, through a registered direct offering, for net proceeds, after placement agent fees and expenses, of approximately $8,142,006. The closing took place on January 26, 2026. The shares of common stock offered by us in this transaction were registered under our shelf registration statement (File No. 333-281622) on Form N-2, which was declared effective by the Securities and Exchange Commission on January 20, 2026.
Lake Street Capital Markets, LLC (“Lake Street”) acted as placement agent for the offering. On January 23, 2026, we executed a placement agency agreement with Lake Street.
A copy of the form of securities purchase agreement and the placement agency agreement are filed herewith as Exhibits 10.1 and 10.2, respectively, and are incorporated herein by reference. The foregoing description of the offering by us, and the documents related thereto, is a summary and is qualified in its entirety by reference to such Exhibits.
Item 8.01 – Other Events
A copy of the opinion of Foley & Lardner LLP relating to the legality of the common stock is filed as Exhibit 5.1 to this report.
Item 9.01 Exhibits
(d) Exhibits. The following exhibit is filed with this Current Report on Form 8-K:
| No. | Description |
|---|---|
| 5.1 | Opinion of Foley & Lardner LLP |
| 10.1 | Form of Securities Purchase Agreement |
| 10.2 | Placement Agency Agreement |
| 23.1 | Consent of Foley & Lardner LLP (included in Exhibit 5.1) |
| 104 | Cover |
| Page Interactive Data File (embedded within the Inline XBRL document |
Field: Page; Sequence: 2
Field: /Page
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| | DAXOR
CORPORATION | |
| --- | --- | --- |
| | (Registrant) | |
| Date:
January 26, 2026 | By: | /s/
Robert J. Michel |
| | Name: | Robert
J. Michel |
| | Title: | Chief
Financial Officer |
Field: Page; Sequence: 3; Options: Last
Field: /Page
Field: Set; Name: xdx; ID: xdx_08B_extensions eJxFjd0KgkAQhZ/Adxj2OkyNvPAyqYgsRCK6XXKKJd2R2a3skXrLJiUaDszf+WaUmqg1rUyDDKdFVcAB267RHqHCCzLaM4oj32wzkFzh1TjP2vqh/YE5CYPCpOFMy3xwPozDOoMoniapSIosnkO5U8F3n5O9mBqtN7oBbWsomTo26DW/xgsH3ZOl9jV8OiI7QzaDOIzG9RuSKE5gTw/9JL45KIpcBZMhArVmunfiWvYe7ZeEZYOtvHMj/VfwAcpBSlo=